ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹394 Cr | ₹159 Cr | ₹98 Cr | ₹69 Cr | ₹74 Cr |
What is the latest Total Non-Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹394 Cr |
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹74 Cr |
How is Total Non-Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹394 Cr | 147.90 | |
| Mar2025 | ₹159 Cr | 62.66 | |
| Mar2024 | ₹98 Cr | 41.80 | |
| Mar2023 | ₹69 Cr | -6.30 | |
| Mar2022 | ₹74 Cr | - | |
Compare Total Non-Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹15,708.1 Cr | 3.5% | 1.5% | -31.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 3.5% |
1.5% |
-31.6% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses